Better Normal, A Silver Lining in 2020
JAFES is Accepted for Indexing in PubMed Central
DOI:
https://doi.org/10.15605/jafes.035.02.15Keywords:
PubMed Central, Covid-19, indexing, new normalAbstract
Amid the uncertainties and challenges brought on by the COVID-19 pandemic, we celebrate another major milestone in the continuing journey of the JAFES. We formally announce here our acceptance to PubMed Central after being included in Scopus and Clarivate Analytics Emerging Sources Citation Index in the last 2 years. Launched in 2000, PubMed Central is a free archive of full-text biomedical and life sciences journal articles, serving as a digital counterpart to the print journal collection of the US National Library of Medicine. As a participating journal, JAFES shall be depositing full text articles starting from 2017 and these shall be available 100% open access and searchable also in MedLine.
Downloads
References
None
Downloads
Published
How to Cite
Issue
Section
License
Journal of the ASEAN Federation of Endocrine Societies is licensed under a Creative Commons Attribution-NonCommercial 4.0 International. (full license at this link: http://creativecommons.org/licenses/by-nc/3.0/legalcode).
To obtain permission to translate/reproduce or download articles or use images FOR COMMERCIAL REUSE/BUSINESS PURPOSES from the Journal of the ASEAN Federation of Endocrine Societies, kindly fill in the Permission Request for Use of Copyrighted Material and return as PDF file to jafes@asia.com or jafes.editor@gmail.com.
A written agreement shall be emailed to the requester should permission be granted.